Veradermics MANE
NYSE MANE
$117.11 -4.12 (-3.40%)
As of: Oct 1, 2026 · 3:59 PM EDT

Veradermics (MANE) Change in Interest Receivables (2026)

Updated

Veradermics (MANE) posted Change in Interest Receivables of $1.28 million for Q2 2026, down 14.5% from the prior quarter.

Analysis

Veradermics (MANE) Change in Interest Receivables (2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Interest Receivables at Veradermics was $2.78 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Interest Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Veradermics 5.07 Bn 5.07 Bn - 1.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.28 Mn
Mar 31, 2026 1.50 Mn
API Access

Veradermics Change in Interest Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-interest-receivables&ticker=MANE&period=max&api_key=YOUR_API_KEY